HPR157 Repurposed Drugs Launched Under the AMNOG in Germany: Effects on Benefit Assessment and Price Development

Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.1286
https://www.valueinhealthjournal.com/article/S1098-3015(22)03491-X/fulltext
Title : HPR157 Repurposed Drugs Launched Under the AMNOG in Germany: Effects on Benefit Assessment and Price Development
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03491-X&doi=10.1016/j.jval.2022.09.1286
First page :
Section Title :
Open access? : No
Section Order : 10836
Categories :
Tags :
Regions :
ViH Article Tags :